At close: December 20 at 4:10:12 PM GMT+11
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
398,302.00
255,353.00
109,813.00
157,821.00
Total Liabilities Net Minority Interest
249,391.00
175,346.00
107,655.00
78,805.00
Total Equity Gross Minority Interest
148,911.00
80,007.00
2,158.00
79,016.00
Total Capitalization
157,120.00
83,319.00
2,158.00
79,111.00
Common Stock Equity
148,911.00
80,007.00
2,158.00
79,016.00
Capital Lease Obligations
8,272.00
7,134.00
2,520.00
1,848.00
Net Tangible Assets
39,248.00
21,023.00
-53,571.00
19,827.00
Working Capital
67,440.00
87,677.00
9,561.00
73,672.00
Invested Capital
158,084.00
83,319.00
2,177.00
79,375.00
Tangible Book Value
39,248.00
21,023.00
-53,571.00
19,827.00
Total Debt
17,445.00
10,446.00
2,539.00
2,207.00
Share Issued
323,727.00
316,343.00
285,073.00
280,405.32
Ordinary Shares Number
323,727.00
316,343.00
285,073.00
280,405.32
12/31/2020 - 11/14/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CU6.AX Clarity Pharmaceuticals Ltd
4.5500
-8.45%
NEU.AX Neuren Pharmaceuticals Limited
12.14
-3.19%
CSL.AX CSL Limited
276.57
-0.80%
CUV.AX Clinuvel Pharmaceuticals Limited
11.79
-1.26%
MSB.AX Mesoblast Limited
2.4200
-20.66%
OCC.AX Orthocell Limited
1.2400
-0.80%
BOT.AX Botanix Pharmaceuticals Limited
0.3650
-6.41%
IMM.AX Immutep Limited
0.3400
-1.45%
IMU.AX Imugene Limited
0.0380
+5.56%
PTX.AX Prescient Therapeutics Limited
0.0410
-2.38%